Reata Pharmaceuticals (RETA) Q1 2023 Earnings

10MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-2.42
-2.22
-2.01
-1.81

Details

Expected EPS
-2.42
Actual EPS
-1.81
Surprise EPS
0.61
Surprise Percent
+25.21%

Description

Reata Pharmaceuticals (RETA) has reported earnings of -1.81 per share for Q1 2023.

0 Comments

Share your thoughts